Latest Publications

Share:

Patent Litigation Update 2024

While the number of filed patent cases is down, it is still the most prevalent type of IP claim. In 2023, there were 3,111 patent cases filed, following a downward trend since 2021, with the Western District of Texas still...more

[Webinar] 2024 North Carolina CLE Institute - February 9th, 9:00 am - 2:00 pm ET

Join us for the 2024 North Carolina CLE Institute, Hosted by Williams Mullen, a virtual legal education program designed to provide timely legal guidance and help you to secure your CLE credits....more

Williams Mullen Manufacturing Edge: IP Considerations for Manufacturers [Video]

In the fourth episode of Williams Mullen Manufacturing Edge, Intellectual Property Partner Rick Matthews identifies the benefits and limitations of patents, copyrights, trademarks, and trade secrets for manufacturers seeking...more

[Event] FIC 2022: Firearms Industry Conference - April 25th - 27th, Atlanta, GA

Williams Mullen’s Firearms Industry Group and Orchid are excited to announce open registration for the revamped 2022 Firearms Industry Conference (FIC), to be held in Atlanta this April. All Federal Firearms Licensees (FFLs)...more

Supreme Court Upholds but Narrows Assignor Estoppel: What This Means For Your Company and its Employees

On June 29, 2021, the Supreme Court published its divisive opinion in Minerva Surgical, Inc. v. Hologic, Inc., Et. Al. The 5-4 decision penned by Justice Kagan upheld the centuries-old doctrine of Assignor Estoppel, while...more

Clearing Up the Confusion as to Preclusion: Supreme Court’s Trademark Ruling Gives Deference to the Trademark Trial and Appeal...

B&B Hardware, Inc. v. Hargis Industries, Inc., 575 U.S. _____ (2015). The U.S. Supreme Court on Tuesday ruled that federal court decisions on “likelihood of confusion” can be precluded by earlier findings on the same...more

Supreme Court Cuts Out a Slice of the Federal Circuit’s De Novo Pie

Recently, the Supreme Court changed the standard of review the Federal Circuit must use when reviewing district court claim construction decisions in patent cases. Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., 574 U.S. ___...more

Supreme Court Agrees to Take Case Assessing Scope of Review for Claim Construction

The Supreme Court on Monday, March 31, 2014, granted certiorari in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Case 13-854 (Mar. 31, 2014), a case that has the potential to overturn years of precedent leading back to the...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide